Axcella Health Inc.
NASDAQ:AXLA
4.58 (USD) • At close September 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Axcella Health Inc. |
Symbool | AXLA |
Munteenheid | USD |
Prijs | 4.58 |
Beurswaarde | 0 |
Dividendpercentage | 0% |
52-weken bereik | 0.36 - 4.58 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. William R. Hinshaw Jr. |
Website | https://www.axcellahealth.com |
An error occurred while fetching data.
Over Axcella Health Inc.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence;
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)